1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001
    Meeting Abstract

    Hamid, O.; Robert, C.; Daud, A.; Hodi, F. S.; Hwu, W. J.; Kefford, R.; Wolchok, J. D.; Hersey, P.; Joseph, R. W.; Weber, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genetic variants including microsatellite instability in metastatic Hürthle cell carcinoma of the thyroid
    Meeting Abstract

    Hale-Wallace, N.; Deshpande, H. A.; Holt, E. H.; Callender, G. G.; Gibson, C.; Lee, G.; Carling, T.; Ho, A. L.; Eder, J. P.; Finberg, K. E.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr)
    Meeting Abstract

    Greally, M.; Chou, J. F.; Molena, D.; Rusch, V. W.; Bains, M. S.; Park, B. J.; Wu, A. J. C.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Results of PROSPECT: A randomized phase 3 trial of PROSTVAC-V/F (PRO) in men with asymptomatic or minimally symptomatic metastatic, castration-resistant prostate cancer
    Meeting Abstract

    Gulley, J. L.; Borre, M.; Vogelzang, N. J.; Ng, S.; Agarwal, N.; Parker, C. C.; Pook, D. W.; Rathenborg, P.; Flaig, T. W.; Carles, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range
    Meeting Abstract

    Goldfarb, S. B.; Carter, J.; Bernick, B.; Mirkin, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of BRCA1 and BRCA2 germline mutations in uterine serous carcinomas and uterine carcinosarcomas
    Meeting Abstract

    Gerber, D.; Dao, F.; Olvera, N.; Piccola, N.; Levine, D. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cost saving analysis of reduced-dose versus standard-dose bevacizumab in recurrent glioblastoma
    Meeting Abstract

    Gleeson, J. P.; Greene, J. P.; Mullally, W. J.; Brady, C.; Goggin, C.; Dennehy, C.; Power, D. G.; Hennessy, B.; Breathnach, O. S.; Bambury, R. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled crossover study
    Meeting Abstract

    Gounder, M. M.; Somaiah, N.; Attia, S.; Chawla, S. P.; Villalobos, V. M.; Chmielowski, B.; Burgess, M. A.; Schwartz, G. K.; Riedel, R. F.; von Mehren, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save